Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 2
1985 2
1986 2
1987 5
1988 2
1989 2
1990 4
1991 2
1992 5
1993 5
1994 12
1995 7
1996 16
1997 9
1998 7
1999 8
2000 14
2001 8
2002 24
2003 17
2004 26
2005 37
2006 37
2007 59
2008 77
2009 65
2010 95
2011 106
2012 128
2013 177
2014 202
2015 274
2016 274
2017 288
2018 362
2019 414
2020 453
2021 475
2022 618
2023 576
2024 535
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,898 results

Results by year

Filters applied: . Clear all
Page 1
Deubiquitylating Enzymes in Cancer and Immunity.
Ren J, Yu P, Liu S, Li R, Niu X, Chen Y, Zhang Z, Zhou F, Zhang L. Ren J, et al. Among authors: niu x. Adv Sci (Weinh). 2023 Dec;10(36):e2303807. doi: 10.1002/advs.202303807. Epub 2023 Oct 27. Adv Sci (Weinh). 2023. PMID: 37888853 Free PMC article. Review.
Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure.
Yang S, Yu Y, Xu Y, Jian F, Song W, Yisimayi A, Wang P, Wang J, Liu J, Yu L, Niu X, Wang J, Wang Y, Shao F, Jin R, Wang Y, Cao Y. Yang S, et al. Among authors: niu x. Lancet Infect Dis. 2024 Feb;24(2):e70-e72. doi: 10.1016/S1473-3099(23)00744-2. Epub 2023 Dec 15. Lancet Infect Dis. 2024. PMID: 38109919 No abstract available.
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting.
Yisimayi A, Song W, Wang J, Jian F, Yu Y, Chen X, Xu Y, Yang S, Niu X, Xiao T, Wang J, Zhao L, Sun H, An R, Zhang N, Wang Y, Wang P, Yu L, Lv Z, Gu Q, Shao F, Jin R, Shen Z, Xie XS, Wang Y, Cao Y. Yisimayi A, et al. Among authors: niu x. Nature. 2024 Jan;625(7993):148-156. doi: 10.1038/s41586-023-06753-7. Epub 2023 Nov 22. Nature. 2024. PMID: 37993710 Free PMC article.
Defect-engineered chiral metal-organic frameworks.
Niu X, Wang Y, Liu Y, Yuan M, Zhang J, Li H, Wang K. Niu X, et al. Mikrochim Acta. 2024 Jul 10;191(8):458. doi: 10.1007/s00604-024-06534-7. Mikrochim Acta. 2024. PMID: 38985164 Review.
Peptide drugs: a new direction in cancer immunotherapy.
Sui X, Niu X, Zhou X, Gao Y. Sui X, et al. Among authors: niu x. Cancer Biol Med. 2023 Dec 7;21(3):198-203. doi: 10.20892/j.issn.2095-3941.2023.0297. Cancer Biol Med. 2023. PMID: 38062861 Free PMC article. No abstract available.
4,898 results